Back to Morgan Stanley Morgan Stanley

RDHL

8 quarters

Position history for Morgan StanleyMorgan Stanley's holdings in Redhill Biopharma Ltd.

Yes. Morgan Stanley holds 1 shares of RDHL (Redhill Biopharma), worth $1, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Morgan Stanley has held RDHL since Q3 2024, across 8 quarterly 13F filings.

Current Value

$1

Current Shares

1

Total Value Change

-$1,572

Total Shares Change

-179

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1
0.0%
$10.0%$0.85
0
2026-Q1
Unchanged
1
0.0%
$10.0%$0.75
0
2025-Q4
Unchanged
1
0.0%
$10.0%$1.03
0
2025-Q3
Decreased
1
-99.9%
$20.0%$2.17
0
2025-Q2
Increased
1,802
+138x
$3,4960.0%$1.94
15
2025-Q1
Decreased
13
-99.4%
$340.0%$2.66
0
2024-Q4
Increased
2,213
+1129.4%
$13,7420.0%$6.21
20
2024-Q3
New
180
-
$1,5730.0%$8.74
17

Other major holders of RDHL: Citadel Advisors LLC, Fédération des caisses Desjardins du Québec, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used